Legal Landscape for GLP-1 Compounding with Shweta Kumar

Tue, Mar 11, 2025 | 11:00 am EDT

On Tuesday, March 11 at 11 am, The Capitol Forum will host Shweta Kumar to discuss legal considerations for companies that compound GLP-1 weight-loss drugs as these blockbuster products start to come off shortage.

To attend the call, you must provide a business email address. Registrations with a personal address will be denied.*

If you need assistance accessing the link, please email info@thecapitolforum-news.com.

Join us to learn more about:

  • What FDA law and regulations say about compounding off-shortage drugs
  • The viability of personalized GLP-1 dosing strategies
  • The potential for patent infringement claims against compounders

Shweta Kumar Bio

Shweta Kumar is a clinical teaching fellow in the Intellectual Property and Information Policy Clinic at Georgetown University, where she focuses on pharmaceutical, patent and FDA law as well as health privacy and patient access. She has published research on the patent litigation risk faced by drug compounders and the intersection of FDA and patent law when it comes to pharmaceutical compounding.

Previously, Kumar worked as an intellectual property lawyer at Goodwin Procter LLP, representing clients across a range of industries. She also served as a legal extern at the Intellectual Property Section of the Department of Justice.

Kumar earned her J.D. from UVA Law and a B.S. in Neuroscience from the College of William & Mary.

Speakers:

Shweta Kumar

Clinical Teaching Fellow in the Intellectual Property and Information Policy Clinic, Georgetown University

Alice Tracey

Correspondent, The Capitol Forum

Reserve your spot today!